“…A translational approach to identifying, optimizing, and implementing preventive behavioral interventions is consistent with the mission of the National Institutes of Health (NIH), which is to seek Bfundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.T ranslational research is defined by the NIH as: (1) Bthe process of applying discoveries generated during research in the laboratory, and in preclinical studies, to the development of trials and studies in humans,^and (2) Bresearch aimed at enhancing the adoption of best practices in the community.^The first area is often referred to as T1 and the second as T2 research. The translational spectrum applied to prevention research can be further broken down into additional categories, resulting in an interactive and dynamic set of research phases as illustrated in Table 1 [1]. As depicted in Table 1, the translational spectrum in prevention research begins with Btype zero^or T0, characterized by basic discovery science and the movement of basic science findings to the next logical step along the translational continuum (e.g., findings on basic principles, mechanisms, and processes in animal models validated with human subjects in field or laboratory settings); continues through T1 (bench to bedside), which involves early stage intervention development and testing; to efficacy and effectiveness (T2) testing; and culminates in the dissemination, adoption and implementation of proven interventions in clinical and community settings (T4), and ultimately at a global level (T3-T5).…”